Comparative study on the prevalence of Staphylococcus aureus imported to intensive care units of a university hospital, Pernambuco, Brazil;Estudo comparativo da prevalência de Staphylococcus aureus importado para as unidades de terapia intensiva de hospital universitário, Pernambuco, Brasil

Revista Brasileira de Epidemiologia

Volumn 9, Issue 4, 2006, Pages 436-446

  Cavalcanti, Silvana Maria De Morais ^a,b   De França, Emmanuel Rodrigues ^a   Vilela, Marinalda Anselmo ^a   Montenegro, Francisco ^a   Cabral, Carlos ^a   Medeiros, Ângela Cristina Rapela ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b NONE   (Brazil)

Author keywords

Intensive therapy unit; Methicillin resistance; Prevalence; Staphylococcus aureus

Indexed keywords

EID: 34047221100     PISSN: 1415790X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-790X2006000400004     Document Type: Article

References (33)

1. a ed.) Salvador: Guanabara Koogan; 2000. p. 157-62.
2. CDC. Centers for Disease Control and Prevention. Laboratory detection of oxacillin/methicillin-resistant Staphylococcus aureus (MRSA); 1999. Disponível em: http://www.cdc.gov/ncidod/hip/Lab/FactSheet/mrsa.htm. Acessado em 4 de dezembro de 2002.
3. CDC. Centers for Disease Control and Prevention. Multidrug-resistant organisms in Non-Hospital Healthcare settings. 2000. Disponível em: http://www.cdc.gov/ncidod/hip/ARESIST/nonhosp.htm. Acessado em 3 de dezembro de 2002.
4. a ed.) Rio de Janeiro: Guanabara Koogan; 1997. p. 163-73.
5. Nouwen J, Van Belkun A, Verbrugh HA. Determinants of Staphylococcus aureus nasal carriage. Netherlands J Med 2001; 59: 126-33.
6. Vandenbergh MFQ, Verbrugh HA. Carriage of Staphylococcus aureus: epidemiology and clinical relevance. J Lab Clin Med 1999; 133: 525-34.
7. CDC. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a State Prison-Mississippi, 2000. MMWR Morb Mortal Weekly Rep 2001; 50(42): 919-22.
8. Elliot MJ, Kellun MT, Tenover FC, Pettriess RL. Nasal carriage of methicillin-resistant Staphylococcus aureus among paramedics in the Sedgwick Medical Service in Wichita, Kansas. Infect Control Hosp Epidemiol 2002; 23(2): 60-3.
9. Tammelin A. et al. Nasal and hand carriage of Staphylococcus aureus in staff at a Department for Thoracic and Cardiovascular Surgery: endogenous or exogenous source? Infect Control Hosp Epidemiol 2003; 24(9): 686-9.
10. CPS-IDIC. Canadian Paediatric Society-Infectious Diseases and Immunization Committee. Control of methicillin-resistant Staphylococcus aureus in Canadian pediatric institutions is still a worthwhile goal. Paediat Child Health 1999; 4(5): 337-41.
11. Perl TM. et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346(24): 1871-7.
12. Von Eiff C. et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344(1): 11-6.
13. Dupeyron C. et al. Staphylococcus aureus nasal carriage in a digestive disease unit. J Hosp Infect 2002; 52: 281-7.
14. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying, mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-20.
15. Beaujean DJMA, Weersink AJL, Blok HEM, Frénay HME, Verhoef J. Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital. J Hosp Infect 1999; 42: 213-8.
16. Martin JN. et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis 1999; 180(3): 869-896.
17. Sissolak D. et al. Risk factors nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains. Eur J Clin Microbiol Infect Dis 2002; 21: 88-96.
18. Shapiro M. et al. Cutaneous microenvironment of human immunodeficiency virus (HIV)-seronegative individuals, with special reference to Staphylococcus aureus colonization. J Clin Microbiol 2000; 38(9): 3174-8.
19. Nguyen MH. et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130: 221-5.
20. Lucet JC. et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003; 163: 181-8.
21. CDC. Centers for Disease Control and Prevention. MRSA-methicillin resistant Staphylococcus aureus. 2003. Disponível em: http://www.cdc.gov/ncidod/hip/Aresist/mrsafaq.htm. Acessado em 6 de março de 2003.
22. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002; 78(921): 385-96.
23. Scanvic A. et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32(10):1393.
24. Kalmeijer MD. et al. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21(5): 319-25.
25. Girou E. et al. Selective screening of carriers for control of methicillin-resistant Staphylococcus. aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis Toronto 1998; 27: 543-50.
26. Papia G. et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999; 20(7): 473-6.
27. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282(18): 1745-51.
28. Girou E. et al. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000; 21(9): 583-90.
29. Talon RD, Bertrand X. Screening in a chronic-care setting. Infect Control Hosp Epidemiol 2001; 22(8): 505-11.
30. Henry FC. The changing epidemiology of Staphylococcus aureus? Emerg Infects Dis 2001; 7(2): ???.
31. Porter R, Subramani K, Thomas AN, Chadwick P. Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significance. Intensive Care Med 2003; 29(4): 655-8.
32. Korn GP. et al. High frequency of colonization and absence of identifiable risk factors for methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units in Brazil. Braz J Infect Dis 2001; 5(1): 1-7.
33. Kenner J. et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24(6): 439-44.